Table 1.
Patient No. | Age (yr) | BMI (kg/m2) | Sex | Ethnicity | Coexisting Conditions | Classification of PAH | Qualifying Right Heart Catheterization | Current PAH/RV Failure Treatment |
---|---|---|---|---|---|---|---|---|
1 | 64 | 16 | F | W | None | Idiopathic | PA mean, 47 mm Hg | Selixipag |
PCWP, 7 mm Hg | Riociguat | |||||||
PVR, 13.3 WU | Ambrisentan | |||||||
Carvedilol | ||||||||
Furosemide | ||||||||
2 | 75 | 34.5 | F | B | Paroxysmal atrial fibrillation | Idiopathic | PA mean, 30 mm Hg | Sildenafil |
PCWP, 7 mm Hg | Oxygen | |||||||
Hypertension | PVR, 6.6 WU | |||||||
Diabetes mellitus | ||||||||
Amlodipine | ||||||||
Bumetanide | ||||||||
3 | 30 | 31.8 | F | W | Secondary Graves’ disease | Idiopathic | PA mean, 49 mm Hg | Tadalafil |
PCWP, 3 mm Hg | Epoprostenol | |||||||
Supraventricular tachycardia | PVR, 17.7 WU | Macitentan | ||||||
Spironolactone | ||||||||
Torsemide | ||||||||
4 | 83 | 34.4 | M | B | Atrial flutter | Idiopathic | PA mean, 46 mm Hg | Sildenafil |
PCWP, 9 mm Hg | Selixipag | |||||||
Diabetes mellitus | PVR, 5.8 WU | Oxygen | ||||||
Metoprolol | ||||||||
Amlodipine | ||||||||
Furosemide | ||||||||
5 | 71 | 33.8 | M | B | Hypertension | Idiopathic | PA mean, 45 mm Hg | Treprostinil |
Diabetes mellitus | PCWP, 15 mm Hg | Oxygen | ||||||
Atrial fibrillation and flutter | PVR, 4.7 WU | Metolazone | ||||||
Carvedilol | ||||||||
Furosemide | ||||||||
6 | 61 | 30.8 | F | W | Hypertension | Idiopathic | PA mean, 39 mm Hg | Sildenafil |
Diabetes mellitus | PCWP, 13 mm Hg | Macitentan | ||||||
PVR, 6.7 WU |
Definition of abbreviations: B = black; BMI = body mass index; PA = pulmonary artery; PAH = pulmonary arterial hypertension; PCWP = pulmonary capillary wedge pressure; PVR = pulmonary vascular resistance; RV = right ventricle; W = white; WU = Wood units.